UPDATE: Morgan Stanley Reiterates on Mead Johnson Nutrition on Details of SEC Inquiry

In a report published Wednesday, Morgan Stanley analyst Matthew Grainger reiterated an Equal-Weight rating on Mead Johnson Nutrition (NYSE: MJN ), but removed the $85.00 price target. In the report, Morgan Stanley noted, “In its updated 10-K filing released this afternoon, MJN provided new disclosure surrounding the SEC's inquiry into